Table: Aska Pharmaceutical - 6-MTH group results

ASKA Pharmaceutical Holdings

06/11/2017 06:00

Nov 6 (Reuters)-  
             Aska Pharmaceutical Co Ltd  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                 6 months ended      6 months ended       Year to  
                Sep 30, 2017        Sep 30, 2016     Mar 31, 2018  
                   LATEST             YEAR-AGO          LATEST     
                   RESULTS             RESULTS         FORECAST    
  Sales             25.05               24.32            50.00     
                 (+3.0 pct)          (+15.2 pct)      (+3.0 pct)   
  Operating          1.87                1.33             2.00     
                 (+40.5 pct)        (+135.6 pct)      (+11.5 pct)  
  Recurring          1.99                1.46             2.10     
                 (+36.9 pct)        (+111.4 pct)      (+4.9 pct)   
  Net                1.64                1.28             1.80     
                 (+28.8 pct)        (+222.2 pct)      (-38.9 pct)  
  EPS             58.35 yen           45.67 yen        64.39 yen   
  Ann Div                             14.00 yen        14.00 yen   
  -Q2 div         7.00 yen            7.00 yen                     
  -Q4 div                             7.00 yen         7.00 yen    
   
  NOTE - Aska Pharmaceutical Co Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4514.T  
  ((Tokyo Headline News Desk +813 6441 1812))